Robert Laugherty,

JD, MBA, PA-C

Robert Laugherty,

JD, MBA, PA-C
Physician Assistant and Director of Rheumatology, East Tennessee Medical Group

Robert Laugherty,

JD, MBA, PA-C
Physician Assistant and Director of Rheumatology, East Tennessee Medical Group
Robert Laugherty, JD, MBA, PA-C, is the director of rheumatology at East Tennessee Medical Group in Alcoa, Tennessee. He earned a bachelor’s degree in journalism from the University of Florida, his juris doctor degree and master of business administration degree from the University of Tennessee, and physician assistant degree from the Medical College of Georgia in 2000. He discovered that rheumatology was his calling after time spent in emergency medicine and internal medicine and has been in the specialty for almost two decades. He is a founding member of Rheumatology Advance Practice Providers, a society devoted to the education and training of physical associates and nurse practitioners in rheumatology practice.

Robert's Shared Resources

Microbiome May Hold Clues to Diagnosing Psoriatic Arthritis With Enthesitis

Researchers explored the role of gut microbiota in patients with psoriatic arthritis (PsA), particularly those presenting with enthesitis and dactylitis,...
Robert Laugherty,
CURATED BY:
Robert Laugherty,
JD, MBA, PA-C

The Cost of Delayed Psoriatic Arthritis Diagnosis and Treatment

A recent, large, real-world study compared early diagnostic and treatment outcomes for patients with psoriatic arthritis (PsA) and rheumatoid arthritis...
Robert Laugherty,
CURATED BY:
Robert Laugherty,
JD, MBA, PA-C

Multimorbidity May Signal Early Psoriatic Arthritis Risk

A population-based cohort study using the Rochester Epidemiology Project assessed the relationship between multimorbidity and the development of psoriatic arthritis...
Robert Laugherty,
CURATED BY:
Robert Laugherty,
JD, MBA, PA-C

CASPAR Criteria Outperform Legacy Tools in Identifying Psoriatic Arthritis

Psoriatic arthritis (PsA) is a systemic, chronic inflammatory arthritis commonly associated with psoriasis and typically seronegative for rheumatoid factor....
Robert Laugherty,
CURATED BY:
Robert Laugherty,
JD, MBA, PA-C

GRAPPA Consensus on Comprehensive Treatment Recommendations for Psoriatic Arthritis

The objective of this study was to develop comprehensive treatment recommendations for the various clinical manifestations of psoriatic arthritis (PsA),...
Robert Laugherty,
CURATED BY:
Robert Laugherty,
JD, MBA, PA-C

Evaluating the Clinical, Economic, and Humanistic Burden of Psoriatic Arthritis

This literature evaluated the clinical, economic, and humanistic burden of psoriatic arthritis (PsA). The review focused on studies published between...
Robert Laugherty,
CURATED BY:
Robert Laugherty,
JD, MBA, PA-C
Share